Commonwealth Equity Services
TCRR

Commonwealth Equity Services’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Commonwealth Equity Services’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,973
Closed -$37 – 3969
2023
Q1 		$37 Buy
24,973
+2,500
+11% +$3.37K ﹤0.01% 3614
2022
Q4 		$22K Buy
+22,473
New +$30.3K ﹤0.01% 3594

Commonwealth Equity Services's TCRR Position: Q2 2023 in Review

Commonwealth Equity Services sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 24,973 shares — an estimated $37 sold.

Commonwealth Equity Services first reported a position in TCRR in Q4 2022 and held it in 2 quarters. The position peaked at $22K in Q4 2022. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

  • Commonwealth Equity Services reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 24,973 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $37.
  • Commonwealth Equity Services first reported a position in TCR2 Therapeutics Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Commonwealth Equity Services's TCR2 Therapeutics Inc. Common Stock position peaked at $22K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.